Total Payments
$33,290
2024 Payments
$552.77
Companies
24
Transactions
304
Medicare Patients
18,684
Medicare Billing
$892,848
Payment Breakdown by Category
Other$14,375 (43.2%)
Research$10,225 (30.7%)
Food & Beverage$5,125 (15.4%)
Travel$3,059 (9.2%)
Consulting$501.00 (1.5%)
Education$5.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,375 | 10 | 43.2% |
| Unspecified | $10,225 | 13 | 30.7% |
| Food and Beverage | $5,125 | 268 | 15.4% |
| Travel and Lodging | $3,059 | 10 | 9.2% |
| Consulting Fee | $501.00 | 2 | 1.5% |
| Education | $5.11 | 1 | 0.0% |
Payments by Type
General
$23,065
291 transactions
Research
$10,225
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $16,824 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,699 | 71 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,297 | 24 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $776.14 | 36 | $0 (2019) |
| PFIZER INC. | $381.98 | 29 | $0 (2024) |
| Abbott Laboratories | $230.51 | 9 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $189.10 | 10 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $150.73 | 6 | $0 (2024) |
| Baxter Healthcare | $140.71 | 6 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $91.41 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $552.77 | 33 | Boston Scientific Corporation ($131.54) |
| 2023 | $2,879 | 41 | Boston Scientific Corporation ($2,428) |
| 2022 | $470.14 | 17 | BOSTON SCIENTIFIC CORPORATION ($228.75) |
| 2021 | $474.32 | 9 | BOSTON SCIENTIFIC CORPORATION ($355.26) |
| 2020 | $4,699 | 20 | Boston Scientific Corporation ($4,502) |
| 2019 | $9,289 | 51 | Boston Scientific Corporation ($4,849) |
| 2018 | $5,650 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,375) |
| 2017 | $9,276 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,990) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: DIABETES | ||||||
| 12/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.63 | General |
| 10/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 10/30/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: DEVICES | ||||||
| 10/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: General - Therapies_CRM | ||||||
| 09/06/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.82 | General |
| 08/07/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: DEVICES | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Cardiovascular | ||||||
| 07/17/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: DEVICES | ||||||
| 07/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.12 | General |
| 06/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $0.14 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $0.33 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $0.05 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 06/11/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/24/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: DEVICES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LONGEVITY STUDY | Boston Scientific Corporation | $5,895 | 10 |
| LONGEVITY STUDY | BOSTON SCIENTIFIC CORPORATION | $4,330 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 4,952 | 7,393 | $813,376 | $225,932 |
| 2022 | 38 | 5,620 | 8,488 | $887,896 | $252,677 |
| 2021 | 44 | 5,520 | 7,863 | $773,137 | $223,180 |
| 2020 | 45 | 2,592 | 3,777 | $608,587 | $191,059 |
Total Patients
18,684
Total Services
27,521
Medicare Billing
$892,848
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 335 | 395 | $77,815 | $33,009 | 42.4% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 51 | 51 | $116,127 | $27,671 | 23.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,437 | 3,682 | $95,732 | $22,393 | 23.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 199 | 341 | $54,182 | $18,208 | 33.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 146 | 165 | $41,910 | $15,375 | 36.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 121 | 226 | $30,510 | $12,943 | 42.4% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 15 | 15 | $33,060 | $8,968 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $23,634 | $8,692 | 36.8% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 21 | 21 | $32,550 | $7,759 | 23.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 265 | 515 | $47,895 | $6,949 | 14.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 171 | 342 | $34,542 | $6,504 | 18.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 56 | 84 | $20,667 | $6,177 | 29.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 68 | 75 | $24,150 | $5,818 | 24.1% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 50 | 85 | $18,619 | $5,550 | 29.8% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 101 | 153 | $12,245 | $4,771 | 39.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 94 | 174 | $34,452 | $3,900 | 11.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 44 | $8,492 | $3,871 | 45.6% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 14 | 14 | $13,370 | $3,385 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 239 | 300 | $17,100 | $2,874 | 16.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 57 | 58 | $11,484 | $2,855 | 24.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 87 | 164 | $12,300 | $2,701 | 22.0% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 26 | 44 | $9,196 | $2,699 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $5,565 | $2,608 | 46.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 28 | 32 | $11,936 | $2,573 | 21.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $7,480 | $2,474 | 33.1% |
About Dr. Michael Allan, MD
Dr. Michael Allan, MD is a Cardiovascular Disease healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124035571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Allan, MD has received a total of $33,290 in payments from pharmaceutical and medical device companies, with $552.77 received in 2024. These payments were reported across 304 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,375).
As a Medicare-enrolled provider, Allan has provided services to 18,684 Medicare beneficiaries, totaling 27,521 services with total Medicare billing of $892,848. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Chattanooga, TN
- Active Since 08/01/2006
- Last Updated 09/01/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1124035571
Products in Payments
- PRADAXA (Drug) $12,643
- WATCHMAN (Device) $3,836
- Clinical Trial Product (Device) $3,435
- ENERGEN (Device) $3,295
- CLINICAL TRIAL PRODUCT (Device) $3,235
- Micra (Device) $1,219
- ENTRESTO (Drug) $776.14
- WATCHMAN Access System (Device) $282.93
- VARIOUS RELEASED ICD FAMILIES (Device) $260.00
- ELIQUIS (Drug) $180.49
- CHANTIX (Drug) $163.93
- WATCHMAN FLX (Device) $142.03
- Hillrom - Carnation Ambulatory Monitor (Device) $119.27
- CARDIVA VASCADE MVP VVCS 6-12F (Device) $99.45
- LifeVest (Device) $91.41
- Inpefa (Drug) $78.65
- BRILINTA (Drug) $73.57
- AMPLATZER (Device) $72.61
- VYNDAQEL (Drug) $71.52
- CARTO 3 (Device) $56.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chattanooga
Dr. Harish Manyam, Md, MD
Cardiovascular Disease — Payments: $355,956
Cardiovascular Disease $355,956
William Blalock, Md, MD
Cardiovascular Disease — Payments: $59,707
Cardiovascular Disease $59,707
Newton Wiggins
Cardiovascular Disease — Payments: $48,698
Cardiovascular Disease $48,698
Dr. John Golding, Md, MD
Cardiovascular Disease — Payments: $26,247
Cardiovascular Disease $26,247
Walter Few, Md, MD
Cardiovascular Disease — Payments: $24,192
Cardiovascular Disease $24,192
Augustus Mealor, Md, MD
Cardiovascular Disease — Payments: $19,638
Cardiovascular Disease $19,638